Indication
Group B Streptococcus
1 clinical trial
1 product
Clinical trial
A Phase 2, Non-Randomized, Controlled, Open-Label, Parallel-Group, Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-pregnant Subjects.Status: Completed, Estimated PCD: 2016-11-02
Product
GBS Trivalent Vaccine